Orca Pharmaceuticals Competitors and Similar CompaniesClear all

Orca Pharmaceuticals's competitors and similar companies include Genentech, UCB, Cipla and Livzon Pharmaceutical Group.
Orca Pharmaceuticals
Orca Pharmaceuticals
Orca Pharmaceuticals is a company that develops oral drugs for the treatment of chronic inflammatory disease.
Genentech
Genentech
Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.
UCB
UCB
UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.
Cipla
Cipla
Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group
Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.
Founding Date
Founding Date
2012
Founding Date
1976
Founding Date
1928
Founding Date
1935
Founding Date
1985
Type
Type
Private
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Milton, GB HQ
Locations
South San Francisco, US HQ
Hillsboro, US
Oceanside, US
Portland, US
South San Francisco, US
South San Francisco, US
South San Francisco, US
see more
Locations
Brussels, BE HQ
Melbourne, AU
Vienna, AT
Braine L'alleud, BE
Braine L'alleud, BE
Leuven, BE
São Paulo, BR
see more
Locations
Mumbai, IN HQ
Melbourne, AU
Antwerpen, BE
São Paulo, BR
São Paulo, BR
Unterhaching, DE
Nairobi, KE
see more
Locations
Zhuhai, CN HQ
Chengdu, CN
Qingyuan, CN
Shanghai, CN
Shaoguan, CN
Shenzhen, CN
Zhuhai, CN
Employees
Employees
N/A
Employees
18,077
Employees
9,052
Employees
27,764
Employees
9,067
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
34.3 b
Valuation ($)
N/A
Valuation ($)
4.2 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
€7.4b (FY, 2025)
Revenue (est.)
₹277.1b (FY, 2026)
Revenue (est.)
¥11.7b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
€1.4b (FY, 2025)
Cost of goods
₹95.5b (FY, 2026)
Cost of goods
¥4.1b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
€7.2b (FY, 2025)
Gross profit
₹195b (FY, 2026)
Gross profit
¥7.8b (FY, 2025)
Net income
Net income
N/A
Net income
N/A
Net income
€1.6b (FY, 2025)
Net income
₹38.7b (FY, 2026)
Net income
¥2.4b (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Genentech
HQ
South San Francisco, US

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines.

View company
UCB
HQ
Brussels, BE
Employees
9,052

UCB is a company that provides biopharmaceutical research and development solutions for neurological and immunological conditions.

View company
Cipla
HQ
Mumbai, IN
Employees
27,764

Cipla is a pharmaceutical company focused on the development, manufacturing, and distribution of medications and healthcare products.

View company
Livzon Pharmaceutical Group
HQ
Zhuhai, CN
Employees
9,067

Livzon Pharmaceutical Group (丽珠医药集团股份有限公司, 丽珠医药) is a pharmaceutical company that engages in the development and production of active pharmaceutical ingredients, biological drugs, diagnostic reagents, and other products.

View company